[go: up one dir, main page]

ATE66614T1 - Insulinzubereitung fuer nicht-parenterale verabreichung. - Google Patents

Insulinzubereitung fuer nicht-parenterale verabreichung.

Info

Publication number
ATE66614T1
ATE66614T1 AT87902450T AT87902450T ATE66614T1 AT E66614 T1 ATE66614 T1 AT E66614T1 AT 87902450 T AT87902450 T AT 87902450T AT 87902450 T AT87902450 T AT 87902450T AT E66614 T1 ATE66614 T1 AT E66614T1
Authority
AT
Austria
Prior art keywords
parenteral administration
pct
insulin
insulin preparation
sec
Prior art date
Application number
AT87902450T
Other languages
English (en)
Inventor
Per Balschmidt
Finn Benned Hansen
Bente Rose Johansen
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Application granted granted Critical
Publication of ATE66614T1 publication Critical patent/ATE66614T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Genetics & Genomics (AREA)
  • Endocrinology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Otolaryngology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
AT87902450T 1986-04-18 1987-04-14 Insulinzubereitung fuer nicht-parenterale verabreichung. ATE66614T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DK179286A DK179286D0 (da) 1986-04-18 1986-04-18 Insulinpraeparat
EP87902450A EP0267208B1 (de) 1986-04-18 1987-04-14 Insulinzubereitung für nicht-parenterale verabreichung
PCT/DK1987/000038 WO1987006137A1 (en) 1986-04-18 1987-04-14 An insulin preparation for non-parenteral administration

Publications (1)

Publication Number Publication Date
ATE66614T1 true ATE66614T1 (de) 1991-09-15

Family

ID=8108089

Family Applications (1)

Application Number Title Priority Date Filing Date
AT87902450T ATE66614T1 (de) 1986-04-18 1987-04-14 Insulinzubereitung fuer nicht-parenterale verabreichung.

Country Status (13)

Country Link
US (1) US5053389A (de)
EP (1) EP0267208B1 (de)
JP (1) JPH01500116A (de)
AT (1) ATE66614T1 (de)
AU (1) AU598543B2 (de)
CA (1) CA1283358C (de)
DE (1) DE3772521D1 (de)
DK (2) DK179286D0 (de)
ES (1) ES2007607A6 (de)
FI (1) FI87529C (de)
IL (1) IL82209A0 (de)
NO (1) NO875299L (de)
WO (1) WO1987006137A1 (de)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0414080B1 (de) * 1989-08-21 1994-02-16 F. Hoffmann-La Roche Ag Insulinzubereitung für nicht-parenterale Verabreichung
IL99699A (en) * 1990-10-10 2002-04-21 Autoimmune Inc Drug with the option of oral, intra-intestinal, or inhaled dosing for suppression of autoimmune response associated with type I diabetes
FR2686899B1 (fr) 1992-01-31 1995-09-01 Rhone Poulenc Rorer Sa Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant.
US6131567A (en) * 1993-01-29 2000-10-17 Aradigm Corporation Method of use of monomeric insulin as a means for improving the reproducibility of inhaled insulin
EP1607086A1 (de) * 1993-01-29 2005-12-21 Aradigm Corporation Verfahren zur Verwendung monomeren Insulins als Mittel zur Verbesserung der Reproduzierbarkeit inhalierten Insulins
TW404844B (en) 1993-04-08 2000-09-11 Oxford Biosciences Ltd Needleless syringe
US6893664B1 (en) 1996-06-17 2005-05-17 Powderject Research Limited Particle delivery techniques
US5948751A (en) * 1996-06-20 1999-09-07 Novo Nordisk A/S X14-mannitol
UA65549C2 (uk) * 1996-11-05 2004-04-15 Елі Ліллі Енд Компані Спосіб регулювання ожиріння шляхом периферійного введення аналогів та похідних glp-1 (варіанти) та фармацевтична композиція
DK1283051T3 (da) * 1997-06-13 2006-10-16 Lilly Co Eli Stabile insulinformuleringer
CO4750643A1 (es) * 1997-06-13 1999-03-31 Lilly Co Eli Formulacion estable de la insulina que contiene l-arginina y protamina
US20010007853A1 (en) * 1998-01-08 2001-07-12 Dimarchi Richard Dennis Method for administering monomeric insulin analogs
US6350458B1 (en) 1998-02-10 2002-02-26 Generex Pharmaceuticals Incorporated Mixed micellar drug deliver system and method of preparation
US7070799B1 (en) * 1998-02-10 2006-07-04 Generex Pharmaceuticals, Inc. Method for administering insulin to the buccal region
US6221378B1 (en) 1998-02-10 2001-04-24 Generex Pharmaceuticals Incorporated Mixed micellar delivery system and method of preparation
US6375975B1 (en) 1998-12-21 2002-04-23 Generex Pharmaceuticals Incorporated Pharmaceutical compositions for buccal and pulmonary application
US6294153B1 (en) 1998-12-21 2001-09-25 Generex Pharmaceuticals, Inc. Aerosol pharmaceutical formulation for pulmonary and nasal delivery
US6849263B2 (en) * 1998-12-21 2005-02-01 Generex Pharmaceutical Incorporated Pharmaceutical compositions for buccal delivery of pain relief medications
US7087215B2 (en) * 1998-12-21 2006-08-08 Generex Pharmaceuticals Incorporated Methods of administering and enhancing absorption of pharmaceutical agents
US6451286B1 (en) 1998-12-21 2002-09-17 Generex Pharmaceuticals Incorporated Pharmaceutical compositions for buccal and pulmonary administration comprising an alkali metal alkyl sulfate and at least three micelle-forming compounds
US6350432B1 (en) 1999-03-19 2002-02-26 Generex Pharmaceuticals Incorporated Pressurized container having an aerosolized pharmaceutical composition
US6485706B1 (en) 1999-06-04 2002-11-26 Delrx Pharmaceutical Corp. Formulations comprising dehydrated particles of pharma-ceutical agents and process for preparing the same
GB2355009A (en) * 1999-07-30 2001-04-11 Univ Glasgow Peptides conjugated to bile acids/salts
EP1276856A4 (de) 2000-04-12 2004-06-09 Human Genome Sciences Inc Albumin fusionsproteine
US8061006B2 (en) 2001-07-26 2011-11-22 Powderject Research Limited Particle cassette, method and kit therefor
AU2002364586A1 (en) 2001-12-21 2003-07-30 Delta Biotechnology Limited Albumin fusion proteins
EP1594530A4 (de) 2003-01-22 2006-10-11 Human Genome Sciences Inc Albuminfusionsproteine
US8147426B2 (en) * 2003-12-31 2012-04-03 Nipro Diagnostics, Inc. Integrated diagnostic test system
US20090099064A1 (en) * 2006-06-08 2009-04-16 Diabecore Medical Inc., Derivatized insulin oligomers
EP2134351B1 (de) 2007-03-13 2016-04-27 Nutrition 21, Inc. Verfahren und zusammensetzungen zur verzögerten freisetzung von chrom
ES2563038T3 (es) * 2007-04-30 2016-03-10 Novo Nordisk A/S Método para secar una composición proteica, una composición proteica seca y una composición farmacéutica que comprende la proteína seca
WO2009002867A2 (en) 2007-06-26 2008-12-31 Nutrition 21, Inc. Multiple unit dosage form having a therapeutic agents in combination with a nutritional supplement
EP2077132A1 (de) 2008-01-02 2009-07-08 Boehringer Ingelheim Pharma GmbH & Co. KG Abgabevorrichtung, Aufbewahrungsvorrichtung und Verfahren zur Abgabe einer Formulierung
JP5670421B2 (ja) 2009-03-31 2015-02-18 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング コンポーネント表面のコーティング方法
EP3508239B1 (de) 2009-05-18 2020-12-23 Boehringer Ingelheim International GmbH Adapter, inhalationseinrichtung und zerstäuber
US10016568B2 (en) 2009-11-25 2018-07-10 Boehringer Ingelheim International Gmbh Nebulizer
JP5658268B2 (ja) 2009-11-25 2015-01-21 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ネブライザ
EP2504052B1 (de) 2009-11-25 2022-07-27 Boehringer Ingelheim International GmbH Zerstäuber
JP5874724B2 (ja) 2010-06-24 2016-03-02 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ネブライザ
US8933022B2 (en) 2011-03-01 2015-01-13 Jds Therapeutics, Llc Methods and compositions for the treatment and prevention Hypoglycemia and related disorders
EP2694220B1 (de) 2011-04-01 2020-05-06 Boehringer Ingelheim International GmbH Medizinisches gerät mit behälter
US9827384B2 (en) 2011-05-23 2017-11-28 Boehringer Ingelheim International Gmbh Nebulizer
WO2013152894A1 (de) 2012-04-13 2013-10-17 Boehringer Ingelheim International Gmbh Zerstäuber mit kodiermitteln
ES2836977T3 (es) 2013-08-09 2021-06-28 Boehringer Ingelheim Int Nebulizador
US9744313B2 (en) 2013-08-09 2017-08-29 Boehringer Ingelheim International Gmbh Nebulizer
CA2948072C (en) 2014-05-07 2023-06-27 Boehringer Ingelheim International Gmbh Nebulizer and container
PL3139984T3 (pl) 2014-05-07 2021-11-08 Boehringer Ingelheim International Gmbh Nebulizator
DK3139979T3 (da) 2014-05-07 2023-10-09 Boehringer Ingelheim Int Enhed, forstøver og fremgangsmåde
MX2018009748A (es) 2016-02-11 2019-02-07 Nutrition 21 Llc Composiciones que contienen cromo para mejorar la salud y el estado físico.

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1381274A (en) * 1971-01-28 1975-01-22 Nat Res Dev Insulin derivatives
GB1381273A (en) * 1971-01-28 1975-01-22 Nat Res Dev Insulin derivatives
IE36225B1 (en) * 1971-01-28 1976-09-15 Nat Res Dev Improvements relating to insulin derivatives
DK135268A (de) * 1973-02-09
US4164573A (en) * 1975-06-13 1979-08-14 Galinsky Alvin M Composition and method for making a suppository for introducing a hypoglycemic agent into a mammal
GB1554157A (en) * 1975-06-13 1979-10-17 Takeda Chemical Industries Ltd Stable insulin preparation for intra nasal administration
US4153689A (en) * 1975-06-13 1979-05-08 Takeda Chemical Industries, Ltd. Stable insulin preparation for nasal administration
GB1527605A (en) * 1975-08-20 1978-10-04 Takeda Chemical Industries Ltd Insulin preparation for intranasal administration
US4442090A (en) * 1980-11-09 1984-04-10 Kyoto Yakuhin Kogyo Kabushiki Kaisha Absorption-promoting compounds, compositions thereof with pharmaceuticals and/or bases for rectal administration and method of use
EP0093551B1 (de) * 1982-04-30 1991-01-16 Ajinomoto Co., Inc. Pharmazeutische Zusammensetzung
JPS58189118A (ja) * 1982-04-30 1983-11-04 Takeda Chem Ind Ltd 経鼻投与製剤
US4534894A (en) * 1982-11-17 1985-08-13 The Rockefeller University Process for sulphation and phosphorylation of proteins and peptides
JPS59163313A (ja) * 1983-03-09 1984-09-14 Teijin Ltd 経鼻投与用ペプチドホルモン類組成物
IL68769A (en) * 1983-05-23 1986-02-28 Hadassah Med Org Pharmaceutical compositions containing insulin for oral administration
US4746508A (en) * 1983-06-06 1988-05-24 Beth Israel Hospital Assn. Drug administration
JPS60224616A (ja) * 1984-04-24 1985-11-09 Teijin Ltd 経鼻投与用組成物

Also Published As

Publication number Publication date
DK160460B (da) 1991-03-18
IL82209A0 (en) 1987-10-30
FI875533A0 (fi) 1987-12-16
US5053389A (en) 1991-10-01
EP0267208A1 (de) 1988-05-18
DK642587A (da) 1987-12-08
FI87529B (fi) 1992-10-15
JPH01500116A (ja) 1989-01-19
DE3772521D1 (de) 1991-10-02
NO875299D0 (no) 1987-12-17
FI87529C (fi) 1993-01-25
ES2007607A6 (es) 1989-07-01
DK160460C (da) 1991-08-26
AU7356187A (en) 1987-11-09
AU598543B2 (en) 1990-06-28
DK642587D0 (da) 1987-12-08
NO875299L (no) 1987-12-17
WO1987006137A1 (en) 1987-10-22
CA1283358C (en) 1991-04-23
EP0267208B1 (de) 1991-08-28
FI875533L (fi) 1987-12-16
DK179286D0 (da) 1986-04-18

Similar Documents

Publication Publication Date Title
ATE66614T1 (de) Insulinzubereitung fuer nicht-parenterale verabreichung.
AU1923088A (en) Piperazinyl derivatives of purines and isosteres thereof as hypoglycemic agents
HUP0002373A2 (hu) Glükagon antagonisták/inverz agonisták és ezeket tartalmazó gyógyászati készítmények
NO904378L (no) Fremgangsmaate for fremstilling av et modifisert protein for terapeutisk anvendelse.
SE8504945L (sv) Farmaceutiska kompositioner innehallande antracyklinglykosider
SE8402560L (sv) Farmaceutisk komposition
IL72469A0 (en) Novel insulin derivatives,processes for their preparation and their use,and pharmaceutical agents for the treatment of diabetes mellitus
DE3575076D1 (de) Katheter fuer rueckinfusion von pharmazeutischen agenten.
FI881061A7 (fi) Hitaasti vapauttavia valmisteita ruoansulatuskanavan ulkopuolisesti annettaviksi ja niiden käyttö.
SE9301290D0 (sv) Anvaendning av en somatostatinanalog
DE68909409D1 (de) Heilmitteldosierung zur verabreichung an fische.
DE3570579D1 (en) Non-dusty blends of meals or flours with additives for use in fodder production
NO871295D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive aminosyrederivater.
NZ223043A (en) Sialic acid derivatives; use as stabilisers for physiologically active substances and as binders in chromatography
EP0177342A3 (de) Orale Formulierungen therapeutischer Proteine
ATE54824T1 (de) System zur arzneistoffabgabe mit erhoehter bioakzeptanz.
NO870049D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive aminosyrederivater.
PT78628B (en) Pharmaceutical composition with reduced toxicity
AU3024389A (en) Therapeutic agent for the prevention of intraventricular hemorrhage in premature infants
FI884240A0 (fi) Menetelmä paikalliseen käyttöön tarkoitetun farmaseuttisen valmisteen valmistamiseksi
DE3874610D1 (de)
ATE116849T1 (de) Pharmazeutische verwendung von fettsäuren.
BG44709A3 (bg) Метод за получаване на 9-хлор-1,5-бензотиазепинови производни
AU7336687A (en) Treatment of basal cell carcinoma intralesionally with recombinant human alpha interferon
ATE126437T1 (de) Verwendung von depogen zur behandlung von eingeschränktem blutkreislauf.